Search by Drug Name or NDC
NDC 47335-0277-23 Tetrabenazine 12.5 mg/1 Details
Tetrabenazine 12.5 mg/1
Tetrabenazine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is TETRABENAZINE.
MedlinePlus Drug Summary
Tetrabenazine is used to treat chorea (sudden movements that you cannot control) caused by Huntington's disease (an inherited disease that causes the progressive breakdown of nerve cells in the brain). Tetrabenazine is in a class of medications called vesicular monoamine transporter 2 (VMAT2) inhibitors. It works by changing the activity of certain natural substances in the brain that affect nerves and muscles.
Related Packages: 47335-0277-23Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tetrabenazine
Product Information
| NDC | 47335-0277 |
|---|---|
| Product ID | 47335-277_86ebe1dd-8c77-4615-8a4c-1e8ec4dc0098 |
| Associated GPIs | 62380070000310 |
| GCN Sequence Number | 064582 |
| GCN Sequence Number Description | tetrabenazine TABLET 12.5 MG ORAL |
| HIC3 | H6L |
| HIC3 Description | DRUGS TO TREAT MOVEMENT DISORDERS |
| GCN | 15508 |
| HICL Sequence Number | 007350 |
| HICL Sequence Number Description | TETRABENAZINE |
| Brand/Generic | Generic |
| Proprietary Name | Tetrabenazine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tetrabenazine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 12.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TETRABENAZINE |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Pharmaceutical Class | Vesicular Monoamine Transporter 2 Inhibitor [EPC], Vesicular Monoamine Transporter 2 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206129 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 47335-0277-23 (47335027723)
| NDC Package Code | 47335-277-23 |
|---|---|
| Billing NDC | 47335027723 |
| Package | 112 TABLET in 1 BOTTLE (47335-277-23) |
| Marketing Start Date | 2015-08-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.19225 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | TETRABENAZINE 12.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis